SUBSCRIBE
SUBSCRIBE
News   Deals

Japan’s Eisai Company, Ltd. (JOBS) to Buy US Drug Firm AkaRx, Inc. for $255 Million

December 18, 2009 | 
1 min read

Bookmark and Share

Reuters -- Japanese drugmaker Eisai said it would buy U.S. drug firm AkaRx Inc for $255 million and as a result cut its annual net profit forecast by about one-third.

Mergers & acquisitions
MORE ON THIS TOPIC
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
February 27, 2025
 · 
1 min read
 · 
Lori Ellis
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Editorial
The BioSpace Book Club Investigates the Biggest Deals of All Time
February 26, 2025
 · 
3 min read
 · 
Annalee Armstrong
Pictured: Facade of Takeda's office in Massachusetts
Collaboration
Takeda Pumps $770M Into Another BridGene Pact to Hit ‘Undruggable’ Targets
February 25, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: bluebird bio logo on wall/device, courtesy of Pavlo Gonchar
Mergers & acquisitions
Bluebird, Facing Cash Crunch, To Go Private In Deal Valued at $30M
February 21, 2025
 · 
3 min read
 · 
Heather McKenzie